CTS Announces Third Quarter 2026 Results

What happened

CTS reported third-quarter 2026 sales of $149.6 million, up 5% from a year earlier. Net income was $17.8 million, or 11.9% of sales, and diluted earnings per share were $0.61, up 15 cents. The company also raised its 2026 outlook.

Confirmed

Global impact / market context

Higher sales and a 42.2% adjusted gross margin, which means profit left after direct production costs, show CTS is keeping more cash per sale. That stronger profitability supports the raised 2026 outlook and funds diversification, including the Millar acquisition in medical markets.

Analyst inference

Diversified end-market sales grew 7% and now make up 60% of total sales, reducing reliance on transportation, which grew just 2%. This mix shift supports steadier revenue across industries and may lead investors to value CTS less as a cyclical auto supplier.

Analyst inference

What to watch

1. Watch whether diversified end-market sales, which grew 7% and are now 60% of total sales, keep expanding faster than transportation sales, which rose only 2%. Confirmed
2. Management intends the Millar acquisition to advance diversification, especially in the medical end market, so watch for details on how Millar contributes to sales and profit. Proposed
3. Because CTS raised its 2026 outlook on record profitability, watch whether adjusted gross margin near 42.2% holds, since weaker profit per sale could pressure the higher guidance. Analyst inference

Evidence

• globenewswire.com